Lighthouse Investment Partners’s Charles River Laboratories CRL Stock Holding History

Lighthouse Investment Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,489	Closed	-$297K	–	779
2025 Q4	$297K	Sell	1,489 -4,011	-73%	-$728K	0.01%	699
2025 Q3	$861K	Buy	+5,500	New	+$874K	0.03%	463
2024 Q2	–	Sell	-13,116	Closed	-$3.55M	–	427
2024 Q1	$3.55M	Buy	+13,116	New	+$3.13M	0.16%	168

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lighthouse Investment Partners's CRL Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 1,489 shares — an estimated $297K sold.

Lighthouse Investment Partners first reported a position in CRL in Q1 2024 and held it in 3 quarters. The position peaked at $3.55M in Q1 2024. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Lighthouse Investment Partners reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 1,489 Charles River Laboratories shares in Q1 2026, an estimated $297K.
Lighthouse Investment Partners first reported a position in Charles River Laboratories in Q1 2024 and held it in 3 quarters.
Lighthouse Investment Partners's Charles River Laboratories position peaked at $3.55M in Q1 2024.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.